ISPC
iSpecimen Inc.
Price Chart
Latest Quote
$2.57
-0.11 (-4.10%)
Current Price
| Previous Close | $2.68 |
| Open | $2.57 |
| Day High | $2.69 |
| Day Low | $2.52 |
| Volume | 41,023 |
Stock Information
| Shares Outstanding | 1.44M |
| Total Debt | $255K |
| Cash Equivalents | $2.82M |
| Revenue | $1.03M |
| Net Income | $-11.10M |
| Sector | Healthcare |
| Industry | Diagnostics & Research |
| Market Cap | $3.69M |
| EPS (TTM) | $-329.05 |
| Exchange | NCM |
đ Comprehensive Analysis
Company Data
| Enterprise Value | $1.29M |
| Sales | $1.03M |
| Income | $-11.10M |
| Book/sh | $1.10 |
| Cash/sh | $1.96 |
| Employees | 7 |
Financial Ratios
| Quick Ratio | 0.53 |
| Current Ratio | 0.62 |
| Debt/Eq | 31.32 |
Returns & Margins
| ROA | -91.78% |
| ROE | -894.59% |
| Gross Margin | -29.64% |
| Operating Margin | -1627.09% |
Ownership
| Insider Ownership | 0.07% |
| Institutional Ownership | 0.92% |
| Insider & Institutional transactions data not available | |
Valuation Ratios
| Forward P/E | -3.25 |
| P/S | 3.59 |
| P/B | 2.34 |
Analyst Data
| Recommendation | none |
Technical Indicators
| SMA20 | $2.85 |
| SMA50 | $3.99 |
| SMA200 | $17.59 |
| RSI | 26.72 |
| ATR | 0.2262 |
| Shares Float | 1.44M |
| Short Float | 16.77% |
| Short Ratio | 0.29 |
| Volatility | 1.62 |
| Rel Volume | 0.40 |
Performance History
| Week | +0.78% |
| Month | -23.96% |
| Quarter | -58.81% |
| 6 Months | -82.73% |
| YTD | -77.53% |
| Year | -92.90% |
| 3 Years | -99.78% |
| 5 Years | -99.96% |
| 10 Years | -99.96% |
Stock Score:
â Premium
Based on debt, profitability, growth, and cash flow metrics
â Premium Feature
Sign up for free to view detailed scoring breakdown â premium is free during our trial period!
Recent Price History
| Date | Close | Volume |
|---|---|---|
| 2026-06-25 | $2.57 | 41,023 |
| 2026-06-24 | $2.68 | 124,900 |
| 2026-06-23 | $2.54 | 25,700 |
| 2026-06-22 | $2.52 | 41,600 |
| 2026-06-18 | $2.59 | 106,600 |
| 2026-06-17 | $2.55 | 60,700 |
| 2026-06-16 | $2.63 | 117,600 |
| 2026-06-15 | $2.83 | 53,200 |
| 2026-06-12 | $2.75 | 108,600 |
| 2026-06-11 | $2.75 | 181,400 |
| 2026-06-10 | $2.68 | 103,200 |
| 2026-06-09 | $2.92 | 203,600 |
| 2026-06-08 | $2.95 | 60,800 |
| 2026-06-05 | $3.02 | 55,000 |
| 2026-06-04 | $3.18 | 81,700 |
| 2026-06-03 | $3.00 | 130,800 |
| 2026-06-02 | $3.07 | 118,200 |
| 2026-06-01 | $3.34 | 90,200 |
| 2026-05-29 | $3.16 | 141,600 |
| 2026-05-28 | $3.32 | 191,000 |
| 2026-05-27 | $3.35 | 2,383,400 |
| 2026-05-26 | $3.38 | 128,100 |
About iSpecimen Inc.
iSpecimen Inc. operates marketplace that provides biospecimens to life science researchers in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. It develops and operates iSpecimen Marketplace, a proprietary online marketplace platform that connects medical researchers who need access to subjects, samples, and data with hospitals, laboratories, and other organizations who have access to them. The company's marketplace offers human biospecimens, including biofluids, such as whole blood, plasma, serum, urine, saliva, sputum, nasopharyngeal material, and cerebral spinal fluid; solid tissue comprising fresh, fixed, and cryopreserved tissue, as well as formalin-fixed paraffin embedded blocks, slides, and curls; and hematopoietic stem and immune cells, including bone marrow, cord blood, whole blood, or sub-components of these tissues, such as peripheral blood mononuclear cells and other isolated cell types. It serves biopharmaceutical companies, in vitro diagnostic companies, and government/academic institutions. iSpecimen Inc. was incorporated in 2009 and is headquartered in Woburn, Massachusetts.
Period:
Loading...
Income Statement (Annual)
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Revenue | ||||
| Reconciled Cost Of Revenue | $1,904,888 | $5,302,712 | $4,820,268 | $4,756,965 |
| Cost Of Revenue | $1,904,888 | $5,302,712 | $4,820,268 | $4,756,965 |
| Total Revenue | $1,928,998 | $9,291,115 | $9,928,184 | $10,402,303 |
| Operating Revenue | $1,928,998 | $9,291,115 | $9,928,184 | $10,402,303 |
| Expenses | ||||
| Interest Expense | $9,918 | $220,074 | $230,785 | $238,963 |
| Total Expenses | $10,906,917 | $22,019,160 | $21,097,533 | $20,588,385 |
| Other Income Expense | $-1,503,443 | $406,181 | $-39,104 | $9,778 |
| Other Non Operating Income Expenses | $-1,503,443 | $406,181 | $-39,104 | $9,778 |
| Net Non Operating Interest Income Expense | $-6,170 | $-175,941 | $108,965 | $-69,618 |
| Interest Expense Non Operating | $9,918 | $220,074 | $230,785 | $238,963 |
| Operating Expense | $9,002,029 | $16,716,448 | $16,277,265 | $15,831,420 |
| Other Operating Expenses | $246,979 | $537,888 | $1,030,403 | $801,125 |
| Selling And Marketing Expense | $2,295,501 | $4,945,269 | $3,955,974 | $3,445,344 |
| General And Administrative Expense | $4,299,734 | $7,703,000 | $7,723,971 | $8,928,664 |
| Income & Earnings | ||||
| Net Income From Continuing Operation Net Minority Interest | $-10,487,532 | $-12,497,805 | $-11,099,488 | $-10,245,922 |
| Net Interest Income | $-6,170 | $-175,941 | $108,965 | $-69,618 |
| Interest Income | $3,748 | $44,133 | $339,750 | $169,345 |
| Normalized Income | $-10,487,532 | $-12,497,805 | $-11,099,488 | $-10,245,922 |
| Net Income From Continuing And Discontinued Operation | $-10,487,532 | $-12,497,805 | $-11,099,488 | $-10,245,922 |
| Total Operating Income As Reported | $-8,977,919 | $-12,728,045 | $-11,169,349 | $-10,186,082 |
| Net Income Common Stockholders | $-10,487,532 | $-12,497,805 | $-11,099,488 | $-10,245,922 |
| Net Income | $-10,487,532 | $-12,497,805 | $-11,099,488 | $-10,245,922 |
| Net Income Including Noncontrolling Interests | $-10,487,532 | $-12,497,805 | $-11,099,488 | $-10,245,922 |
| Net Income Continuous Operations | $-10,487,532 | $-12,497,805 | $-11,099,488 | $-10,245,922 |
| Pretax Income | $-10,487,532 | $-12,497,805 | $-11,099,488 | $-10,245,922 |
| Interest Income Non Operating | $3,748 | $44,133 | $339,750 | $169,345 |
| Operating Income | $-8,977,919 | $-12,728,045 | $-11,169,349 | $-10,186,082 |
| Gross Profit | $24,110 | $3,988,403 | $5,107,916 | $5,645,338 |
| Special Income Charges | - | - | - | $0 |
| Per Share | ||||
| Diluted EPS | $-91.20 | $-703.20 | $-982.00 | $-928.00 |
| Basic EPS | $-91.20 | $-703.20 | $-982.00 | $-928.00 |
| Other | ||||
| Tax Effect Of Unusual Items | $0 | $0 | $0 | $0 |
| Tax Rate For Calcs | $0 | $0 | $0 | $0 |
| Normalized EBITDA (Bullshit earnings) | $-8,746,712 | $-9,983,483 | $-8,753,555 | $-8,801,760 |
| Reconciled Depreciation | $1,730,902 | $2,294,248 | $2,115,148 | $1,205,199 |
| EBITDA (Bullshit earnings) | $-8,746,712 | $-9,983,483 | $-8,753,555 | $-8,801,760 |
| EBIT | $-10,477,614 | $-12,277,731 | $-10,868,703 | $-10,006,959 |
| Diluted Average Shares | $115,061 | $17,771 | $11,301 | $11,055 |
| Basic Average Shares | $115,061 | $17,771 | $11,301 | $11,055 |
| Diluted NI Availto Com Stockholders | $-10,487,532 | $-12,497,805 | $-11,099,488 | $-10,245,922 |
| Research And Development | $2,159,815 | $3,530,291 | $3,566,917 | $2,656,287 |
| Selling General And Administration | $6,595,235 | $12,648,269 | $11,679,945 | $12,374,008 |
| Other Gand A | $4,299,734 | $7,703,000 | $7,723,971 | $8,928,664 |
| Total Unusual Items | - | - | - | $0 |
| Total Unusual Items Excluding Goodwill | - | - | - | $0 |
| Other Special Charges | - | - | - | - |
| Gain On Sale Of Security | - | - | - | - |
Fetched: 2026-06-22
Balance Sheet (Annual)
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Assets | ||||
| Net Tangible Assets | $818,214 | $-2,017,646 | $2,509,788 | $15,805,383 |
| Total Assets | $9,531,410 | $9,350,230 | $15,819,137 | $24,617,653 |
| Total Non Current Assets | $2,576,820 | $5,762,294 | $7,580,534 | $4,941,932 |
| Non Current Prepaid Assets | $12,100 | $12,100 | $27,601 | $27,601 |
| Goodwill And Other Intangible Assets | $2,270,017 | $5,328,654 | $7,231,289 | $4,503,787 |
| Other Intangible Assets | $2,270,017 | $5,328,654 | $7,231,289 | $4,503,787 |
| Current Assets | $6,954,590 | $3,587,936 | $8,238,603 | $19,675,721 |
| Other Current Assets | $25,457 | $219,782 | $292,079 | $300,434 |
| Inventory | $0 | $45,110 | - | - |
| Receivables | $48,298 | $1,444,636 | $2,940,926 | $4,066,577 |
| Accounts Receivable | $48,298 | $1,444,636 | $728,388 | $1,597,915 |
| Allowance For Doubtful Accounts Receivable | $-646,067 | $-620,433 | $-520,897 | $-230,999 |
| Gross Accounts Receivable | $694,365 | $2,065,069 | $1,249,285 | $1,828,914 |
| Cash Cash Equivalents And Short Term Investments | $6,880,835 | $1,878,408 | $5,005,598 | $15,308,710 |
| Cash And Cash Equivalents | $6,880,835 | $1,878,408 | $2,343,666 | $15,308,710 |
| Other Receivables | - | - | $2,212,538 | $2,327,789 |
| Taxes Receivable | - | - | $0 | $140,873 |
| Cash Financial | - | - | - | $15,308,710 |
| Prepaid Assets | - | - | - | - |
| Debt | ||||
| Total Debt | $268,798 | $312,167 | $196,244 | $185,847 |
| Long Term Debt And Capital Lease Obligation | $211,873 | $268,798 | $29,130 | $27,396 |
| Current Debt And Capital Lease Obligation | $56,925 | $43,369 | $167,114 | $158,451 |
| Long Term Debt | - | - | - | - |
| Liabilities | ||||
| Total Liabilities Net Minority Interest | $6,443,179 | $6,039,222 | $6,078,060 | $4,308,483 |
| Total Non Current Liabilities Net Minority Interest | $211,873 | $268,798 | $29,130 | $27,396 |
| Current Liabilities | $6,231,306 | $5,770,424 | $6,048,930 | $4,281,087 |
| Current Deferred Liabilities | $192,535 | $360,708 | $415,771 | $132,335 |
| Payables And Accrued Expenses | $5,981,846 | $5,366,347 | $5,466,045 | $3,990,301 |
| Payables | $5,362,604 | $4,197,561 | $3,925,438 | $2,459,063 |
| Accounts Payable | $5,362,604 | $4,197,561 | $3,925,438 | $2,459,063 |
| Interest Payable | - | - | - | $0 |
| Equity | ||||
| Common Stock Equity | $3,088,230 | $3,311,008 | $9,741,077 | $20,309,170 |
| Preferred Stock Equity | $1 | - | - | - |
| Total Equity Gross Minority Interest | $3,088,231 | $3,311,008 | $9,741,077 | $20,309,170 |
| Stockholders Equity | $3,088,231 | $3,311,008 | $9,741,077 | $20,309,170 |
| Gains Losses Not Affecting Retained Earnings | $0 | $0 | $840 | $0 |
| Retained Earnings | $-82,350,149 | $-71,862,617 | $-59,364,812 | $-48,265,324 |
| Other Equity Adjustments | - | - | $840 | - |
| Other | ||||
| Treasury Shares Number | $38 | $38 | $38 | $38 |
| Ordinary Shares Number | $211,964 | $42,422 | $11,354 | $11,157 |
| Share Issued | $212,002 | $42,460 | $11,392 | $11,195 |
| Tangible Book Value | $818,213 | $-2,017,646 | $2,509,788 | $15,805,383 |
| Invested Capital | $3,088,230 | $3,311,008 | $9,741,077 | $20,309,170 |
| Working Capital | $723,284 | $-2,182,488 | $2,189,673 | $15,394,634 |
| Capital Lease Obligations | $268,798 | $312,167 | $196,244 | $185,847 |
| Total Capitalization | $3,088,231 | $3,311,008 | $9,741,077 | $20,309,170 |
| Treasury Stock | $172 | $172 | $172 | $172 |
| Additional Paid In Capital | $85,437,703 | $75,173,627 | $69,105,176 | $68,573,774 |
| Capital Stock | $849 | $170 | $45 | $892 |
| Common Stock | $848 | $170 | $45 | $892 |
| Preferred Stock | $1 | $0 | - | - |
| Long Term Capital Lease Obligation | $211,873 | $268,798 | $29,130 | $27,396 |
| Current Deferred Revenue | $192,535 | $360,708 | $415,771 | $132,335 |
| Current Capital Lease Obligation | $56,925 | $43,369 | $167,114 | $158,451 |
| Current Accrued Expenses | $619,242 | $1,168,786 | $1,540,607 | $1,531,238 |
| Net PPE | $294,703 | $421,540 | $321,644 | $410,544 |
| Accumulated Depreciation | $-410,539 | $-342,065 | $-444,731 | $-327,188 |
| Gross PPE | $705,242 | $763,605 | $766,375 | $737,732 |
| Leases | $12,646 | $12,646 | $68,471 | $60,441 |
| Other Properties | $304,668 | $304,668 | $320,826 | $320,826 |
| Machinery Furniture Equipment | $118,768 | $118,314 | $183,221 | $171,773 |
| Buildings And Improvements | $269,160 | $327,977 | $193,857 | $184,692 |
| Properties | $0 | $0 | $0 | $0 |
| Other Short Term Investments | - | $0 | $2,661,932 | $0 |
Fetched: 2026-06-22
Cash Flow Statement (Annual)
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Free Cash Flow | ||||
| Free Cash Flow | $-5,241,062 | $-8,973,547 | $-10,552,135 | $-9,008,910 |
| Operating Activities | ||||
| Operating Cash Flow | $-4,240,608 | $-8,263,713 | $-5,807,550 | $-5,817,720 |
| Cash Flow From Continuing Operating Activities | $-4,240,608 | $-8,263,713 | $-5,807,550 | $-5,817,720 |
| Operating Gains Losses | - | $738 | - | - |
| Investing Activities | ||||
| Capital Expenditure | $-1,000,454 | $-709,834 | $-4,744,585 | $-3,191,190 |
| Investing Cash Flow | $-1,000,454 | $1,979,554 | $-7,228,383 | $-3,191,190 |
| Cash Flow From Continuing Investing Activities | $-1,000,454 | $1,979,554 | $-7,228,383 | $-3,191,190 |
| Capital Expenditure Reported | $-1,000,000 | $-653,288 | $-4,725,107 | $-2,975,686 |
| Financing Activities | ||||
| Issuance Of Capital Stock | $11,249,572 | $1,892,856 | $0 | $0 |
| Financing Cash Flow | $10,243,489 | $5,818,901 | $70,889 | $-3,421,359 |
| Cash Flow From Continuing Financing Activities | $10,243,489 | $5,818,901 | $70,889 | $-3,421,359 |
| Net Other Financing Charges | $-1,006,083 | $-621,477 | - | - |
| Net Preferred Stock Issuance | $5,500,000 | $0 | - | - |
| Preferred Stock Issuance | $5,500,000 | $0 | - | - |
| Net Common Stock Issuance | $5,749,572 | $1,892,856 | $0 | $0 |
| Common Stock Issuance | $5,749,572 | $1,892,856 | $0 | $0 |
| Other | ||||
| Interest Paid Supplemental Data | $1,948 | $14,358 | $16,001 | $161,579 |
| End Cash Position | $6,880,835 | $1,878,408 | $2,343,666 | $15,308,710 |
| Beginning Cash Position | $1,878,408 | $2,343,666 | $15,308,710 | $27,738,979 |
| Changes In Cash | $5,002,427 | $-465,258 | $-12,965,044 | $-12,430,269 |
| Proceeds From Stock Option Exercised | $0 | $4,547,522 | $70,889 | $78,641 |
| Net Investment Purchase And Sale | $0 | $2,689,388 | $-2,483,798 | $0 |
| Sale Of Investment | $0 | $3,150,320 | $10,556,000 | $0 |
| Purchase Of Investment | $0 | $-460,932 | $-13,039,798 | $0 |
| Net PPE Purchase And Sale | $-454 | $-56,546 | $-19,478 | $-215,504 |
| Purchase Of PPE | $-454 | $-56,546 | $-19,478 | $-215,504 |
| Change In Working Capital | $2,113,684 | $-502,668 | $2,589,379 | $2,354,175 |
| Change In Other Working Capital | $-168,173 | $-55,063 | $283,436 | $-522,411 |
| Change In Other Current Liabilities | $-43,369 | $-120,203 | $-155,960 | $-147,276 |
| Change In Other Current Assets | $58,817 | $127,006 | $157,192 | $148,431 |
| Change In Payables And Accrued Expense | $690,499 | $-99,698 | $1,475,744 | $2,139,653 |
| Change In Accrued Expense | $-549,544 | $-371,821 | $9,369 | $513,268 |
| Change In Payable | $1,240,043 | $272,123 | $1,466,375 | $1,626,385 |
| Change In Account Payable | $1,240,043 | $272,123 | $1,466,375 | $1,626,385 |
| Change In Prepaid Assets | $194,325 | $42,688 | $8,355 | $26,601 |
| Change In Inventory | $45,110 | $0 | - | - |
| Change In Receivables | $1,336,475 | $-397,398 | $820,612 | $709,177 |
| Changes In Account Receivables | $1,336,475 | $-903,329 | $564,488 | $1,297,946 |
| Other Non Cash Items | $-75,000 | $-28,976 | $-177,294 | $83,634 |
| Stock Based Compensation | $21,266 | $249,675 | $459,666 | $678,613 |
| Asset Impairment Charge | $2,456,072 | $2,221,075 | $305,039 | $106,581 |
| Depreciation Amortization Depletion | $1,730,902 | $2,294,248 | $2,115,148 | $1,205,199 |
| Depreciation And Amortization | $1,730,902 | $2,294,248 | $2,115,148 | $1,205,199 |
| Amortization Cash Flow | $1,662,428 | $2,228,536 | $1,997,605 | $1,182,766 |
| Amortization Of Intangibles | $1,662,428 | $2,228,536 | $1,997,605 | $1,182,766 |
| Depreciation | $68,474 | $65,712 | $117,543 | $22,433 |
| Gain Loss On Sale Of PPE | $0 | $58 | $0 | - |
| Net Income From Continuing Operations | $-10,487,532 | $-12,497,805 | $-11,099,488 | $-10,245,922 |
| Gain Loss On Investment Securities | - | $680 | - | - |
| Repayment Of Debt | - | - | $0 | $-3,500,000 |
| Net Issuance Payments Of Debt | - | - | $0 | $-3,500,000 |
| Net Long Term Debt Issuance | - | - | $0 | $-3,500,000 |
| Long Term Debt Payments | - | - | $0 | $-3,500,000 |
| Change In Interest Payable | - | - | $0 | $-8,167 |
| Issuance Of Debt | - | - | - | $0 |
| Income Tax Paid Supplemental Data | - | - | - | $0 |
| Long Term Debt Issuance | - | - | - | $0 |
| Net Intangibles Purchase And Sale | - | - | - | - |
| Purchase Of Intangibles | - | - | - | - |
Fetched: 2026-06-22